• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血管性水肿致 C1 抑制剂缺乏症 1 例,初始症状发生 40 年后出现反复腹痛。

A case of hereditary angioedema due to C1-inhibitor deficiency with recurrent abdominal pain diagnosed 40 years after the occurrence of the initial symptom.

机构信息

Department of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Nephrology Unit, Internal Medicine, Saiyu Soka Hospital, 1-7-22 Matsubara, Soka, Saitama, 340-0041, Japan.

出版信息

Clin J Gastroenterol. 2021 Aug;14(4):1175-1179. doi: 10.1007/s12328-021-01338-1. Epub 2021 Feb 5.

DOI:10.1007/s12328-021-01338-1
PMID:33544288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8298325/
Abstract

Hereditary angioedema due to C1-inhibitor deficiency (HAE-C1-INH) is a rare disease, which induces an acute attack of angioedema mediated by bradykinin. HAE-C1-INH can cause serious abdominal pain when severe edema develops in the gastrointestinal tract. However, because it takes a long time, 13.8 years on average in Japan, from the occurrence of the initial symptom to the diagnosis due to low awareness of the disease, undiagnosed HAE-C1-INH patients sometimes undergo unnecessary surgical procedures for severe abdominal pain. We herein present a 56-year-old patient with HAE-C1-INH, who underwent numerous abdominal operations. He frequently needed hospitalization with the administration of opioid due to severe abdominal pain. However, after he was accurately diagnosed with HAE-C1-INH at 55 years of age, he could start self-administration for an acute attack with icatibant, a selective bradykinin B2 receptor antagonist. Consequently, he did not need hospitalizing for ten months after the beginning of the treatment. A series of an accurate diagnosis and appropriate treatment for HAE-C1-INH improved his quality of life. Thus, HAE-C1-INH should be considered, when we meet patients with unidentified recurrent abdominal pain. This case highlights significance of an early diagnosis and appropriate treatment for HAE-C1-INH.

摘要

遗传性血管性水肿伴 C1 酯酶抑制剂缺乏症(HAE-C1-INH)是一种罕见疾病,由缓激肽介导导致急性血管性水肿发作。当胃肠道严重水肿时,HAE-C1-INH 可引起严重腹痛。然而,由于对该病的认识不足,从最初症状发生到确诊平均需要 13.8 年的时间,因此未确诊的 HAE-C1-INH 患者有时会因严重腹痛而接受不必要的手术。本文报告了一位 56 岁 HAE-C1-INH 患者,他接受了多次腹部手术。由于严重腹痛,他经常需要住院并使用阿片类药物。然而,在他 55 岁时被准确诊断为 HAE-C1-INH 后,他可以开始使用依替巴肽(一种选择性缓激肽 B2 受体拮抗剂)进行急性发作的自我治疗。因此,在开始治疗后的十个月内,他无需住院。一系列准确的诊断和适当的治疗改善了他的生活质量。因此,当我们遇到不明原因的复发性腹痛患者时,应考虑 HAE-C1-INH。本病例强调了早期诊断和适当治疗 HAE-C1-INH 的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb68/8298325/dcaaa0920d41/12328_2021_1338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb68/8298325/9f9e8f52f1ce/12328_2021_1338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb68/8298325/dcaaa0920d41/12328_2021_1338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb68/8298325/9f9e8f52f1ce/12328_2021_1338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb68/8298325/dcaaa0920d41/12328_2021_1338_Fig2_HTML.jpg

相似文献

1
A case of hereditary angioedema due to C1-inhibitor deficiency with recurrent abdominal pain diagnosed 40 years after the occurrence of the initial symptom.遗传性血管性水肿致 C1 抑制剂缺乏症 1 例,初始症状发生 40 年后出现反复腹痛。
Clin J Gastroenterol. 2021 Aug;14(4):1175-1179. doi: 10.1007/s12328-021-01338-1. Epub 2021 Feb 5.
2
Bradykinin mediated gastrointestinal edema as a cause of abdominal attacks in patients with hereditary angioedema due to C1-inhibitor deficiency.缓激肽介导的胃肠道水肿是 C1 酯酶抑制剂缺乏所致遗传性血管性水肿患者腹部发作的原因。
J Physiol Pharmacol. 2022 Apr;73(2). doi: 10.26402/jpp.2022.2.08. Epub 2022 Sep 29.
3
The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.认识和管理一种罕见的血管性水肿的重要性:C1 抑制剂缺乏引起的遗传性血管性水肿。
Postgrad Med. 2021 Aug;133(6):639-650. doi: 10.1080/00325481.2021.1905364. Epub 2021 Jul 6.
4
The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.遗传性C1抑制剂缺乏所致血管性水肿治疗的安全性
Expert Opin Drug Saf. 2015;14(11):1725-36. doi: 10.1517/14740338.2015.1094053. Epub 2015 Oct 1.
5
Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.遗传性血管性水肿伴正常 C1 抑制剂:法国队列的临床特征和依替巴肽治疗反应。
Immun Inflamm Dis. 2017 Jan 11;5(1):29-36. doi: 10.1002/iid3.137. eCollection 2017 Mar.
6
Diagnosis and treatment of hereditary angioedema.遗传性血管性水肿的诊断与治疗。
Panminerva Med. 2012 Sep;54(3):241-53.
7
Unnecessary Abdominal Surgeries in Attacks of Hereditary Angioedema with Normal C1 Inhibitor.遗传性血管性水肿发作时 C1 抑制剂正常而施行的不必要腹部手术
Clin Rev Allergy Immunol. 2021 Aug;61(1):60-65. doi: 10.1007/s12016-021-08852-7. Epub 2021 Mar 23.
8
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.获得性血管性水肿与遗传性血管性水肿(I/II型)的比较:依卡替班疗效调查结果
Clin Exp Immunol. 2017 Apr;188(1):148-153. doi: 10.1111/cei.12910. Epub 2017 Feb 9.
9
Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks.日本遗传性血管性水肿的管理:聚焦艾替班特治疗急性发作。
Allergol Int. 2021 Jan;70(1):45-54. doi: 10.1016/j.alit.2020.07.008. Epub 2020 Sep 9.
10
Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study.依替巴肽在巴西 1 型或 2 型遗传性血管性水肿(HAE)和 C1-INH 水平正常的 HAE 患者中的应用:依替巴肽结局调查登记研究的结果。
An Bras Dermatol. 2022 Jul-Aug;97(4):448-457. doi: 10.1016/j.abd.2021.09.009. Epub 2022 May 30.

引用本文的文献

1
Multidisciplinary Prophylactic Strategies for Recurrence of Laryngeal Edema After Tooth Extraction in a Patient With Hereditary Angioedema: A Case Report.遗传性血管性水肿患者拔牙后喉水肿复发的多学科预防策略:一例报告
Cureus. 2023 Oct 11;15(10):e46869. doi: 10.7759/cureus.46869. eCollection 2023 Oct.